AAA
CNTA
Affinity Asset Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
900,162
-646,500
| -42% | -$8.5M | 1.62% | 19 |
|
|
2025
Q1 | $22.2M | Buy |
1,546,662
+450,738
| +41% | +$6.48M | 2.12% | 8 |
|
|
2024
Q4 | $18.4M | Buy |
1,095,924
+130,312
| +13% | +$2.18M | 2.46% | 12 |
|
|
2024
Q3 | $15.4M | Sell |
965,612
-170,090
| -15% | -$2.72M | 2.11% | 13 |
|
|
2024
Q2 | $10.3M | Buy |
1,135,702
+305,156
| +37% | +$2.76M | 1.18% | 21 |
|
|
2024
Q1 | $9.39M | Buy |
830,546
+34,817
| +4% | +$393K | 1.16% | 23 |
|
|
2023
Q4 | $6.33M | Sell |
795,729
-222,362
| -22% | -$1.77M | 1.16% | 23 |
|
|
2023
Q3 | $6.59M | Buy |
1,018,091
+117,368
| +13% | +$759K | 1.85% | 16 |
|
|
2023
Q2 | $5.58M | Buy |
900,723
+216,596
| +32% | +$1.34M | 1.95% | 14 |
|
|
2023
Q1 | $2.63M | Buy |
684,127
+223,799
| +49% | +$862K | 0.87% | 28 |
|
|
2022
Q4 | $1.43M | Buy |
460,328
+217,811
| +90% | +$675K | 0.56% | 37 |
|
|
2022
Q3 | $975K | Buy |
+242,517
| New | +$975K | 0.27% | 38 |
|
|
2022
Q2 | – | Sell |
-65,282
| Closed | -$586K | – | 45 |
|
|
2022
Q1 | $586K | Sell |
65,282
-353,862
| -84% | -$3.18M | 0.09% | 42 |
|
|
2021
Q4 | $4.72M | Buy |
419,144
+215,961
| +106% | +$2.43M | 1.71% | 21 |
|
|
2021
Q3 | $3.39M | Buy |
203,183
+136,226
| +203% | +$2.27M | 0.86% | 25 |
|
|
2021
Q2 | $1.49M | Buy |
+66,957
| New | +$1.49M | 0.53% | 37 |
|